| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/09/1998 | WO1998029109A1 Methods and compositions for identification of autoantigens |
| 07/09/1998 | WO1998029105A2 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations |
| 07/09/1998 | WO1998029101A1 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 07/09/1998 | WO1998029098A1 Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes |
| 07/09/1998 | WO1998029096A1 Aerosolized hydrophobic drug |
| 07/09/1998 | WO1998029069A2 Method for changing the refractive power of an eye |
| 07/09/1998 | WO1998023639A3 Shk toxin compositions and methods of use |
| 07/09/1998 | WO1998021334A3 Antibody mg1 recognizing a small subset of human hematopoietic cells |
| 07/09/1998 | WO1998021320A3 Tissue type plasminogen activator (t-pa) variants: compositions and methods of use |
| 07/09/1998 | WO1998021232A3 Mutant forms of fas ligand and uses thereof |
| 07/09/1998 | WO1998020836A3 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
| 07/09/1998 | WO1998018818A3 Hepatitis b inhibitors |
| 07/09/1998 | WO1998017796A3 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 07/09/1998 | WO1998015635A3 Treatment of cancer using a recombinant poxvirus containing a nucleic acid sequence encoding a cytokine |
| 07/09/1998 | WO1998011234A3 Human protein kinases |
| 07/09/1998 | WO1998009642A3 Therapeutic chemokine antagonists |
| 07/09/1998 | WO1998008542A3 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 07/09/1998 | WO1998007745A3 Compositions and methods for treating infections using analogues of indolicidin |
| 07/09/1998 | WO1998005780A3 Voltage-gated calcium channel antagonist and methods |
| 07/09/1998 | CA2650204A1 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 07/09/1998 | CA2278340A1 Novel human apoptosis regulator |
| 07/09/1998 | CA2278031A1 G-rich oligo aptamers and methods of modulating an immune response |
| 07/09/1998 | CA2276490A1 Antigenic peptides reacting with anti-ovary antibodies |
| 07/09/1998 | CA2276465A1 Method of treating prostatic diseases using delayed and/or sustained release vitamin d formulations |
| 07/09/1998 | CA2276450A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 07/09/1998 | CA2276184A1 Brain targeted low molecular weight hydrophobic antioxidant compounds |
| 07/09/1998 | CA2276177A1 Orthodontic remedy containing pth |
| 07/09/1998 | CA2276091A1 Cell membrane-directed drugs |
| 07/09/1998 | CA2276049A1 Method for elevating the concentration of free insulin-like growth factor |
| 07/09/1998 | CA2275975A1 Human mage-like protein |
| 07/09/1998 | CA2275544A1 Lebetin peptides as platelet aggregation inhibitors |
| 07/08/1998 | EP0852236A1 Anti-inflammatory agent |
| 07/08/1998 | EP0852233A1 Cyclosporin phosphate derivatives and medicinal composition |
| 07/08/1998 | EP0852232A1 Cyclic peptide compounds for pain treatment and their production process |
| 07/08/1998 | EP0852144A2 Enhancing keratinocyte migration and proliferation |
| 07/08/1998 | EP0851931A1 Subtilisin inhibitor of streptomyces venezuelae, and use of the gene sequences for expression and/or secretion of heterologous proteins in streptomyces |
| 07/08/1998 | EP0851929A1 CYTIDINE DEAMINASE cDNA AS A POSITIVE SELECTABLE MARKER FOR GENE TRANSFER, GENE THERAPY AND PROTEIN SYNTHESIS |
| 07/08/1998 | EP0851927A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/08/1998 | EP0851926A2 Variants of human recombinant interferon-gamma (rhu-ifn-gamma) having increased heat-stability |
| 07/08/1998 | EP0851925A1 Human growth hormone variants |
| 07/08/1998 | EP0851924A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 07/08/1998 | EP0851923A2 Fmr1-related protein |
| 07/08/1998 | EP0851922A1 Cyclin depenpent kinase binding compounds |
| 07/08/1998 | EP0851921A1 Genetic alterations related to familial alzheimer's disease |
| 07/08/1998 | EP0851920A1 Variants of vascular endothelial cell growth factor, their uses, and processes for their porduction |
| 07/08/1998 | EP0851919A1 Antisense oligonucleotide chemotherapy for benign hyperplasia or cancer of the prostate |
| 07/08/1998 | EP0851918A2 Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed |
| 07/08/1998 | EP0851876A1 Antisecretory factor peptides regulating pathological permeability changes |
| 07/08/1998 | EP0851875A2 Dna sequences and secreted proteins encoded thereby |
| 07/08/1998 | EP0851872A2 Urogenital carcinoma tlp complex peptides and antibodies thereof |
| 07/08/1998 | EP0851871A1 Inhibition of tumor growth |
| 07/08/1998 | EP0851869A1 Breast specific genes and proteins |
| 07/08/1998 | EP0851770A2 Bifunctional sulphide-containing sulphonamide s 2?ny-type chelate-forming agents for radioisotopes |
| 07/08/1998 | EP0851768A2 Interactive molecular conjugates |
| 07/08/1998 | EP0851767A1 Transcytosis vehicles and enhancers for drug delivery |
| 07/08/1998 | EP0851765A1 Therapeutic and prophylactic methods using heat shock proteins |
| 07/08/1998 | EP0851764A1 Heat shock protein-based vaccines and immunotherapies |
| 07/08/1998 | EP0851763A1 Method and composition for enhanced parenteral nutrition |
| 07/08/1998 | EP0851762A1 Pharmaceutical combination preparations containing erythropoietin and iron preparations |
| 07/08/1998 | EP0851757A2 A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus |
| 07/08/1998 | EP0851753A1 Aerosol compositions |
| 07/08/1998 | EP0788388A4 Device for aerosolized delivery of peptide drugs |
| 07/08/1998 | EP0777478A4 Inhibitors of rotamase enzyme activity |
| 07/08/1998 | EP0730589B1 Isoxazoline compounds useful as fibrinogen receptor antagonists |
| 07/08/1998 | EP0671004B1 Allergen/inflammatory testing and diagnosis |
| 07/08/1998 | EP0667959A4 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE -g(b)-AMYLOID PEPTIDE. |
| 07/08/1998 | EP0626857B1 Improved peritoneal dialysis solutions with polypeptides |
| 07/08/1998 | EP0619841B1 T-cadherin adhesion molecule |
| 07/08/1998 | EP0611306B1 Hemoglobins as drug delivery agents |
| 07/08/1998 | EP0587815B1 Hypertonic isochloremic formulation for circulatory shock |
| 07/08/1998 | EP0528931B1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use |
| 07/08/1998 | EP0504291B1 Novel proteins with oncostatin m activity and process for their preparation |
| 07/08/1998 | EP0398955B1 Diagnosis of retinoblastoma |
| 07/08/1998 | CN1187217A Botulinum toxin derivatives able to modify peripheral sensory afferent functions |
| 07/08/1998 | CN1187203A Method for treatment of corticosteroid induced osteopenia |
| 07/08/1998 | CN1187201A Inhibitors of fibrin cross-linking and/or transglutaminases |
| 07/08/1998 | CN1187199A Novel dolastatin derivatives, their preparation and use |
| 07/08/1998 | CN1187198A Novel dolastatin derivatives, their preparation and use |
| 07/08/1998 | CN1187188A Small molecule inhibitors of rotamase enzyme activity |
| 07/08/1998 | CN1187135A Thrombopoietin compositions |
| 07/08/1998 | CN1187134A Composition for sustained release of non-aggregated erythropoietin |
| 07/08/1998 | CN1187133A Use of angiotensin II type 2 receptor agonists in tissue repair |
| 07/08/1998 | CN1187120A Composition for sustained release of human growth hormone |
| 07/08/1998 | CN1187119A Peptide/protein suspension formulations |
| 07/08/1998 | CN1186695A Recombinant coccidiosis vaccines |
| 07/08/1998 | CN1039015C Polyethylene glycol-interferon conjugates |
| 07/08/1998 | CN1039008C Dual action inhibitors in angiotensin invertase and neutral endopeptidase |
| 07/07/1998 | US5777193 Animals with targeted gene disruption |
| 07/07/1998 | US5777153 Useful for transfecting nucleic acids or peptides into prokaryotic or eukaryotic cells |
| 07/07/1998 | US5777112 Piperazine amides for feeds |
| 07/07/1998 | US5777097 Oligonucleotides comprising a region of a cytokine suppressive anti-inflammatory drug binding protein |
| 07/07/1998 | US5777093 cDNAs associated with ataxia-telangiectasia |
| 07/07/1998 | US5777084 Antibody BV10A4H2 specific for human FLT3/FLK2 receptor and mybridoma |
| 07/07/1998 | US5777083 Stress protein epitopes |
| 07/07/1998 | US5777081 Process for producing an inter-alpha-trypsin inhibitor concentrate for therapeutic use and concentrate thus obtained |
| 07/07/1998 | US5777078 Inactive staphylococcal a-toxin protein |
| 07/07/1998 | US5777075 Octacyclodepsipeptides having an endoparasiticidal action |
| 07/07/1998 | US5777074 Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1) |
| 07/07/1998 | US5777073 Cyclic CRF antagonist peptides |
| 07/07/1998 | US5776971 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |